Debbie Law
About Debbie Law
Debbie Law is the Senior Vice President of Tumor Microenvironment TRC at Bristol Myers Squibb, with over 20 years of experience in the biotechnology and pharmaceutical industry, focusing on immunology and oncology.
Current Role at Bristol Myers Squibb
Debbie Law currently serves as the Senior Vice President of the Tumor Microenvironment TRC at Bristol Myers Squibb. She operates out of Redwood City, California. In her role, she focuses on pioneering research in the field of tumor microenvironments, leveraging her extensive experience in immunology and oncology to drive innovative solutions for cancer treatment.
Previous Experience at Janssen Biopharma
From 2018 to 2020, Debbie Law worked at Janssen Biopharma as the Head of Research for Infectious Disease and SSF Site Head. In this role, she led research programs and advanced initiatives targeting infectious diseases. Her efforts were pivotal in enhancing the research capabilities of the organization during her tenure.
Experience at Jounce Therapeutics
Between 2015 and 2018, Debbie Law was the Chief Scientific Officer (CSO) at Jounce Therapeutics, working in Palo Alto and Boston. At Jounce, she spearheaded research programs aimed at developing new oncology therapies. Her leadership contributed significantly to advancing therapeutic candidates towards clinical trials.
Educational Background in Immunology
Debbie Law holds a DPhil in Immunology from the University of Oxford, completed between 1986 and 1989. Prior to that, she earned a B.Sc in Immunology from the University of Glasgow, where she studied from 1982 to 1986. Her academic background laid the foundation for a robust career in the biotechnology and pharmaceutical industry.
Career in Biotechnology and Pharmaceuticals
With over 20 years of experience, Debbie Law has held significant roles in companies such as Merck, Ablynx, PDL BioPharma, Eos Biotechnology, and COR Therapeutics. She has consistently focused on immunology and oncology, bridging the gap between scientific research and practical applications. Her work has led to the development of several therapeutic candidates that advanced to clinical trials, demonstrating her expertise in managing large-scale research projects and leading teams in complex scientific endeavors.